Hadrien Mary
@hadim.bsky.social
🔬 Deputy CTO @ BeLiver | 🧬 Decoding Biology for Precision Oncology | Former @valence_ai @RecursionPharma | 🌴 https://linktr.ee/hadrien.mary
Reposted by Hadrien Mary
🚀 Big news! BeLiver is now part of the UNITEC Bordeaux (unitec.fr) incubator! We're developing AI-powered predictive tests using proteomics to personalize liver cancer (HCC) treatment. Joining UNITEC provides key resources & network to accelerate our mission. Exciting times ahead! #Biotech #oncology
April 29, 2025 at 11:23 AM
🚀 Big news! BeLiver is now part of the UNITEC Bordeaux (unitec.fr) incubator! We're developing AI-powered predictive tests using proteomics to personalize liver cancer (HCC) treatment. Joining UNITEC provides key resources & network to accelerate our mission. Exciting times ahead! #Biotech #oncology
Reposted by Hadrien Mary
#WorldLiverDay! Fighting liver cancer requires understanding individual tumor biology. Predicting treatment response is key. BeLiver leverages proteomics & AI 🔬🧠 to uncover these insights, aiming for truly personalized therapies & improved patient journeys. #LiverHealth #PrecisionOncology 💡
April 19, 2025 at 5:57 PM
#WorldLiverDay! Fighting liver cancer requires understanding individual tumor biology. Predicting treatment response is key. BeLiver leverages proteomics & AI 🔬🧠 to uncover these insights, aiming for truly personalized therapies & improved patient journeys. #LiverHealth #PrecisionOncology 💡
Reposted by Hadrien Mary
Hello BlueSky!
👋 BeLiver here, a new biotech startup joining from Bordeaux 🇫🇷.
We're focused on the challenge of predicting treatment response in liver cancer (HCC).
Our approach explores using proteomics + AI, aiming to help oncologists make more personalized decisions.
#BioTech #AI #Proteomics
👋 BeLiver here, a new biotech startup joining from Bordeaux 🇫🇷.
We're focused on the challenge of predicting treatment response in liver cancer (HCC).
Our approach explores using proteomics + AI, aiming to help oncologists make more personalized decisions.
#BioTech #AI #Proteomics
April 15, 2025 at 5:40 PM
Hello BlueSky!
👋 BeLiver here, a new biotech startup joining from Bordeaux 🇫🇷.
We're focused on the challenge of predicting treatment response in liver cancer (HCC).
Our approach explores using proteomics + AI, aiming to help oncologists make more personalized decisions.
#BioTech #AI #Proteomics
👋 BeLiver here, a new biotech startup joining from Bordeaux 🇫🇷.
We're focused on the challenge of predicting treatment response in liver cancer (HCC).
Our approach explores using proteomics + AI, aiming to help oncologists make more personalized decisions.
#BioTech #AI #Proteomics
